CNSX:GRIN

Grindrod Shipping Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Grindrod Shipping (CNSX:GRIN) Vs. RIV, WLLW, LABS, KHRN, DN, and META

Should you be buying GRIN stock or one of its competitors? Companies in the industry of "drug manufacturers—specialty & generic" are considered alternatives and competitors to Grindrod Shipping, including RIV Capital (RIV), Willow Biosciences Inc. (WLLW.TO) (WLLW), MediPharm Labs (LABS), Khiron Life Sciences (KHRN), Delta 9 Cannabis (DN), and Meta Growth (META).

Grindrod Shipping (CNSX:GRIN) and RIV Capital (TSE:RIV) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, earnings, institutional ownership and valuation.

Analyst Ratings

This is a breakdown of recent ratings for Grindrod Shipping and RIV Capital, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Grindrod Shipping00103.00
RIV Capital01002.00

Grindrod Shipping currently has a consensus target price of $0.73, indicating a potential upside of ∞. RIV Capital has a consensus target price of C$4.00, indicating a potential upside of 90.48%. Given Grindrod Shipping's stronger consensus rating and higher possible upside, research analysts clearly believe Grindrod Shipping is more favorable than RIV Capital.

Earnings & Valuation

This table compares Grindrod Shipping and RIV Capital's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Grindrod ShippingN/AN/AN/AN/AN/A
RIV CapitalC$15.44 million19.03C$-106,223,568.00C($0.76)-2.77

Grindrod Shipping has higher earnings, but lower revenue than RIV Capital.

Profitability

This table compares Grindrod Shipping and RIV Capital's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Grindrod ShippingN/AN/AN/A
RIV CapitalN/AN/AN/A

Summary

Grindrod Shipping beats RIV Capital on 3 of the 4 factors compared between the two stocks.

Willow Biosciences Inc. (WLLW.TO) (TSE:WLLW) and Grindrod Shipping (CNSX:GRIN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability.

Analyst Recommendations

This is a summary of recent ratings and target prices for Willow Biosciences Inc. (WLLW.TO) and Grindrod Shipping, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Willow Biosciences Inc. (WLLW.TO)0000N/A
Grindrod Shipping00103.00

Willow Biosciences Inc. (WLLW.TO) currently has a consensus target price of C$2.25, indicating a potential upside of 74.42%. Grindrod Shipping has a consensus target price of $0.73, indicating a potential upside of ∞. Given Grindrod Shipping's higher probable upside, analysts clearly believe Grindrod Shipping is more favorable than Willow Biosciences Inc. (WLLW.TO).

Valuation and Earnings

This table compares Willow Biosciences Inc. (WLLW.TO) and Grindrod Shipping's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Willow Biosciences Inc. (WLLW.TO)C$10,000.0015,901.57$-51,032,952.00C($0.41)-3.12
Grindrod ShippingN/AN/AN/AN/AN/A

Grindrod Shipping has lower revenue, but higher earnings than Willow Biosciences Inc. (WLLW.TO).

Profitability

This table compares Willow Biosciences Inc. (WLLW.TO) and Grindrod Shipping's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Willow Biosciences Inc. (WLLW.TO)N/AN/AN/A
Grindrod ShippingN/AN/AN/A

Summary

Grindrod Shipping beats Willow Biosciences Inc. (WLLW.TO) on 2 of the 3 factors compared between the two stocks.

MediPharm Labs (TSE:LABS) and Grindrod Shipping (CNSX:GRIN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability.

Analyst Recommendations

This is a summary of recent ratings and target prices for MediPharm Labs and Grindrod Shipping, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
MediPharm Labs02023.00
Grindrod Shipping00103.00

MediPharm Labs currently has a consensus target price of C$1.53, indicating a potential upside of 218.75%. Grindrod Shipping has a consensus target price of $0.73, indicating a potential upside of ∞. Given Grindrod Shipping's higher probable upside, analysts clearly believe Grindrod Shipping is more favorable than MediPharm Labs.

Valuation and Earnings

This table compares MediPharm Labs and Grindrod Shipping's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$36.01 million3.44$-123,815,040.00C($0.48)-1.00
Grindrod ShippingN/AN/AN/AN/AN/A

Grindrod Shipping has lower revenue, but higher earnings than MediPharm Labs.

Profitability

This table compares MediPharm Labs and Grindrod Shipping's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
MediPharm LabsN/AN/AN/A
Grindrod ShippingN/AN/AN/A

Khiron Life Sciences (CVE:KHRN) and Grindrod Shipping (CNSX:GRIN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability.

Analyst Recommendations

This is a summary of recent ratings and target prices for Khiron Life Sciences and Grindrod Shipping, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Khiron Life Sciences0000N/A
Grindrod Shipping00103.00

Khiron Life Sciences currently has a consensus target price of C$1.20, indicating a potential upside of 122.22%. Grindrod Shipping has a consensus target price of $0.73, indicating a potential upside of ∞. Given Grindrod Shipping's higher probable upside, analysts clearly believe Grindrod Shipping is more favorable than Khiron Life Sciences.

Valuation and Earnings

This table compares Khiron Life Sciences and Grindrod Shipping's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Khiron Life SciencesC$8.01 million10.12$-39,493,921.00C($0.26)-2.05
Grindrod ShippingN/AN/AN/AN/AN/A

Grindrod Shipping has lower revenue, but higher earnings than Khiron Life Sciences.

Profitability

This table compares Khiron Life Sciences and Grindrod Shipping's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Khiron Life SciencesN/AN/AN/A
Grindrod ShippingN/AN/AN/A

Summary

Grindrod Shipping beats Khiron Life Sciences on 2 of the 3 factors compared between the two stocks.

Delta 9 Cannabis (TSE:DN) and Grindrod Shipping (CNSX:GRIN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability.

Valuation and Earnings

This table compares Delta 9 Cannabis and Grindrod Shipping's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Delta 9 CannabisC$52.05 million1.14$-7,346,808.00C($0.07)-8.06
Grindrod ShippingN/AN/AN/AN/AN/A

Grindrod Shipping has lower revenue, but higher earnings than Delta 9 Cannabis.

Analyst Recommendations

This is a summary of recent ratings and target prices for Delta 9 Cannabis and Grindrod Shipping, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Delta 9 Cannabis00014.00
Grindrod Shipping00103.00

Delta 9 Cannabis currently has a consensus target price of C$1.24, indicating a potential upside of 113.79%. Grindrod Shipping has a consensus target price of $0.73, indicating a potential upside of ∞. Given Grindrod Shipping's higher probable upside, analysts clearly believe Grindrod Shipping is more favorable than Delta 9 Cannabis.

Profitability

This table compares Delta 9 Cannabis and Grindrod Shipping's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Delta 9 CannabisN/AN/AN/A
Grindrod ShippingN/AN/AN/A

Summary

Delta 9 Cannabis beats Grindrod Shipping on 3 of the 5 factors compared between the two stocks.

Grindrod Shipping (CNSX:GRIN) and Meta Growth (CVE:META) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability.

Earnings & Valuation

This table compares Grindrod Shipping and Meta Growth's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Grindrod ShippingN/AN/AN/AN/AN/A
Meta GrowthC$60.96 million0.54C$-50,412,840.00C($0.21)-0.66

Grindrod Shipping has higher earnings, but lower revenue than Meta Growth.

Analyst Ratings

This is a summary of recent ratings and price targets for Grindrod Shipping and Meta Growth, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Grindrod Shipping00103.00
Meta Growth0000N/A

Grindrod Shipping presently has a consensus price target of $0.73, suggesting a potential upside of ∞. Given Grindrod Shipping's higher probable upside, research analysts plainly believe Grindrod Shipping is more favorable than Meta Growth.

Profitability

This table compares Grindrod Shipping and Meta Growth's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Grindrod ShippingN/AN/AN/A
Meta GrowthN/AN/AN/A

Summary

Grindrod Shipping beats Meta Growth on 2 of the 3 factors compared between the two stocks.


Grindrod Shipping Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
RIV
RIV Capital
0.8$2.10flatC$293.90 millionC$15.44 million-2.77
WLLW
Willow Biosciences Inc. (WLLW.TO)
1.1$1.29flatC$159.02 millionC$10,000.00-3.12
LABS
MediPharm Labs
1.4$0.48flatC$123.82 millionC$36.01 million-1.00Gap Up
KHRN
Khiron Life Sciences
0.9$0.54flatC$67.34 millionC$8.01 million-2.05
DN
Delta 9 Cannabis
1.4$0.58flatC$59.18 millionC$52.05 million-8.06
META
Meta Growth
0.8$0.14flatC$36.69 millionC$60.96 million-0.66Gap Up
NRTH
48North Cannabis
0.7$0.18flatC$36.44 millionC$17.36 million-0.67
CSI
(CSI)
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
BAMM
28896
0.5N/AN/A$0.00N/A0.00High Trading Volume
ATT
Abattis Bioceuticals
0.5N/AN/AC$0.00N/A0.00Gap Down
AGRA
Agraflora Organics International
1.4N/AN/A$0.00N/A0.00High Trading Volume
IMCC
IM Cannabis
0.0N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
PULL
Mind Cure Health
1.7N/AN/A$0.00N/A0.00High Trading Volume
SPR
Spirit AeroSystems
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
BUZZ
VanEck Vectors Social Sentiment ETF
1.0N/AN/A$0.00N/A0.00High Trading Volume
VIDA
Vidaroo
0.5N/AN/A$0.00N/A0.00High Trading Volume
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.